Which doctors prescribe, and on what grounds. Prescribing happens elsewhere.
Page directoryAsk your regular doctor whether they can help with your concern or whether a specialist is needed. This guide sees no patients, writes no prescriptions and books no visits.
Read about prescribing
In a peptide, small pieces called amino acids join into a short chain, like beads on a string. Proteins contain these same small building blocks.
The word names a kind of substance. Bring the question down to a product name and a purpose for using it.
A peptide product may be an approved medicine. It may instead be made for one person through compounding, or it may be an unapproved drug. This describes U.S. rules as they stood September 26, 2026.
In compounding, a pharmacist or a doctor makes a preparation for a particular person’s needs.
Bring the conversation back to the health concern you want assessed. Prepare your history, ask who will review it, and request a full account of what you would pay.
Telehealth is a visit conducted remotely. Ask how to contact the person reviewing your concern. The word clinician means a health professional involved in care, such as a doctor. Ask whether that person can prescribe.
Get the product name in writing. Then ask what evidence supports that particular use and which record supports any claim of approval. A pharmacy’s identity matters too.
Request a source you can open and a clear account of how it supports the proposed treatment.
Look for a reason that can be discussed, rather than a treatment selected before the conversation begins.
Tell the doctor what has prompted the visit. Ask what they think is happening, what they hope a medicine would change, and what other choices deserve a look. A decision to wait or discuss another approach can be part of that conversation.
A treatment menu alone cannot take the place of an assessment. That is the point of May 2026 guidance from the national group of state medical boards.
Write down the medicines and supplements you already take, the care you have tried, and the questions you keep returning to. Bring records you want the doctor to consider. Ask which parts of that history change the choices being discussed.
The medical boards’ telehealth policy calls for arranging needed tests or referring a person for an examination when the assessment requires it.
Ask who you can speak with before agreeing to a plan and afterward. Write down anything that sounds unclear. Request an explanation in ordinary words, including why this medicine was proposed and how the plan would be reviewed.
Its guidance from May 2026 also requires room for the patient’s questions, with a clinician available to respond.
Under the U.S. rules checked September 26, 2026, a compounded medicine has no FDA approval.
The Food and Drug Administration carries out federal drug reviews. Its short name is FDA. It does not check a compounded product’s safety, effectiveness or quality before that product is sold.
Is the proposed medicine an approved finished product, or is it a compounded preparation? Get the answer for the product itself.
Check the distinction
The search for doctors prescribing peptides can become a search for someone willing to say yes. A better question to take into a visit is: what, exactly, are we trying to treat?
Choose the kind of visit you want to explore: a local in-person clinic or licensed telehealth care. Ask who will assess the concern and whether the service can arrange an examination if one is needed.
The doctor needs to meet the license rules where they work. They also need a license or other legal permission for your state, based on your physical location when care is given. This is the federal guidance checked September 26, 2026.
Check the doctor’s full name through the relevant state medical board. Its public records show license status and public disciplinary history; they do not tell you how well a doctor will meet your needs.
Prepare for the visit